Pasture Holdings Ltd.
SSGX:UUK0.08
SGD
0.00
(0.00%)
ISIN
SGXE54661850
Return %
Stock
S&P 500
1Y
-36.44
14.20
3Y
-60.73
81.12
5Y
- -
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Semi-annual Revenue
USD
•
in mil. unless spec.Semi-annual Earnings Per Share
USD
•
in mil. unless spec.Semi-annual Dividends Per Share
USD
•
in mil. unless spec.Company Description
- CEO
- Chin Kum Soong
- Full Time Employees
- 25
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- Singapore Singapore
- IPO Date
- Jun 9, 2023
- Website
- pasturegroup.com
- Similar Companies
- Business
- Pasture Holdings Ltd. is a Singapore-based global pharmaceutical wholesale distributor, medical supplies provider, and healthtech company. Founded in 1996 and headquartered in Singapore, the company specializes in the sourcing, cold-chain distribution, marketing, and commercialization of specialty pharmaceuticals, generic and branded medications, medical devices, and personal protective equipment across the Asia-Pacific region, North America, Europe, and the Middle East. The company operates across three principal business divisions: Pharmaceutical Wholesale and Distribution; Masks and Medical Consumables; and Digital Health and Other Services. Its product and service portfolio comprises: cold-chain and temperature-sensitive specialty pharmaceuticals, including oncology drugs, vaccines, biologics, and orphan medications for rare diseases; branded and generic prescription drugs as well as over-the-counter health remedies; proprietary respiratory protection and personal protective equipment marketed under the Pasture brand, featuring US FDA-cleared and NIOSH-certified N95 surgical respirators, particulate respirators, medical-grade face masks, and antimicrobial smart masks; hospital consumables, surgical disposables, and diagnostic devices; animal health and veterinary supplies, including companion animal pharmaceuticals and specialty supplements; specialized cold-chain third-party logistics (3PL), inventory warehousing, and cross-border regulatory compliance support; and business-to-business (B2B) digital pharmaceutical procurement platforms and tele-pharmacy service portals serving hospitals, clinics, retail pharmacies, government health authorities, and wholesale distributors. In recent developments, Pasture Holdings successfully completed its initial public offering (IPO) and listed on the Catalist board of the Singapore Exchange under the stock ticker SGX:UUK, raising capital to accelerate regional market penetration, upgrade cold-chain distribution infrastructure, and invest in healthtech capabilities. The group has entered into strategic distribution agreements and commercial partnerships with international pharmaceutical manufacturers to expand access to high-value oncology and specialty therapies across Southeast Asia. Furthermore, Pasture Holdings has diversified its commercial reach by scaling its digital B2B ordering platform and expanding its animal healthcare distribution division, broadening its operations to capture growing demand in veterinary medicine alongside its core human healthcare operations.